Though the findings of the FDA advisory panel are nonbinding, the FDA usually sides with the panel, which may lead to oral phenylephrine products being removed from store shelves in the near future

Sudafed, Benadryl and most decongestants don’t work: FDA advisory panel

By News on the Net -- New York Post——Bio and Archives--September 12, 2023

News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us

An advisory panel of the Food and Drug Administration stated today that virtually all over-the-counter decongestants simply don’t work.

The FDA panel found that phenylephrine — the active ingredient in Sudafed, Benadryl, Robitussin and other popular decongestants — is nearly useless at reducing nasal congestion. ---More...

Support Canada Free Press

View Comments

News on the Net——Bio and Archives

News from around the world

Though the findings of the FDA advisory panel are nonbinding, the FDA usually sides with the panel, which may lead to oral phenylephrine products being removed from store shelves in the near future

Sudafed, Benadryl and most decongestants don’t work: FDA advisory panel

VIEW Comments